Background: Adiponectin, a cytokine secreted by adipocytes, plays an important role in regulating glucose and lipid metabolism. However, the role of adiponectin in pain conditions is largely unknown. This study aimed to identify the role and mechanism of adiponectin in nociceptive sensitivity under physiological and pathological states utilising adiponectin knockout (KO) mice. Methods: Wild type (WT) and adiponectin KO mice were subjected to partial sciatic nerve ligation (pSNL) or sham operation. Pain-like behavioural tests, including thermal allodynia, hyperalgesia, and mechanical allodynia, were performed before and after pSNL from Day 3e21. Dorsal root ganglions (DRGs), lumbar spinal segments at L3-5, and somatosensory cortex were collected for protein measurement via western blotting and immunofluorescence staining. Results: Compared with WT mice, KO mice had significantly lower (40e50%) paw withdrawal latency to innocuous and noxious stimuli before and after pSNL. In DRG neurones from KO mice, where adiponectin receptor (AdipoR) 2 is located, phosphorylated p38 mitogen-activated protein kinase (p-p38 MAPK) and heat-sensitive transient receptor potential cation channel subfamily V member 1 (TRPV1) were significantly higher (by two-to three-fold) than from WT mice. In spinal microglia and somatosensory cortical neurones, where AdipoR1 is mainly located, p-p38 MAPK and TRPV1 were also higher (by two-to three-fold) in KO compared with WT mice, and altered signalling of these molecules was exacerbated (1.2-to 1.3-fold) by pSNL. Conclusions: Our results show that adiponectin regulates thermal nociceptive sensitivity by inhibiting activation of DRG neurones, spinal microglia, and somatosensory cortical neurones in physiological and neuropathic pain states. This study has relevance for patients with adiponectin disorders, such as obesity and diabetes.
acts in the brain to control energy expenditure and body weight, 6, 8 and inhibits glial cells in the brain to reduce inflammation. 9 More recently, adiponectin deficiency in aged mice was reported to lead to spatial memory and learning impairments and fear-conditioned memory deficit, and anxiety. 10 Adiponectin is also involved in exercise-induced hippocampal neurogenesis and antidepressant effects in mice. 11 Although the role of adiponectin in the brain has been well documented, 12 its effect in the spinal cord has been rarely studied. A study reported that intrathecal injection of adiponectin attenuated carrageenan-induced inflammatory pain in rats 13 and obese rats with inflammatory hyperalgesia had decreased concentrations of adiponectin in the spinal cord.
14 Adiponectin is also capable of suppressing spinal cord autoinflammation in experimental autoimmune encephalomyelitis. 15 However, the molecular mechanism governing the effect of adiponectin in nociception and inflammation in the spinal cord under physiological and pathological conditions, such as neuropathic pain, is not clear. Neuropathic pain is evoked by injury in the somatosensory nervous system and characterised as chronic burning or stabbing pain. Neuropathic pain can also manifest as refractory pain from normally innocuous stimuli (i.e. allodynia) and higher than expected pain from noxious stimuli (hyperalgesia). Peripheral nerve injury not only results in dysfunction of sensory neurones per se and their central projection pathways, but also leads to neurogenic inflammatory responses. 16 In the periphery, neurogenic inflammation can be induced by heat-sensitive transient receptor potential cation channel subfamily V member 1 (TRPV1) activation or nerve injury, and established by release of neuropeptides, such as calcitonin gene-related peptide (CGRP) and pro-inflammatory cytokines, leading to peripheral sensitisation. 17, 18 In the spinal cord, neuroinflammation can be triggered by the increased peripheral neuronal activity and lead to immune responses including the release of inflammatory mediators, such as tumour necrosis factor-a (TNF-a), interleukin (IL)-1b, and IL-6, contributing to central sensitisation. 19 Moreover, it has been known that activation of p38 mitogen-activated protein kinase (p38 MAPK) after nerve injury promotes longterm changes in synaptic plasticity, resulting in persistent neuropathic pain. 20, 21 In a peripheral neuropathic pain model, TRPV1 is expressed in cortical neurones and contributes to synaptic strength. 22 Given the potent effects of adiponectin in regulating neuroinflammation and its involvement in pain processing as described previously, we therefore hypothesised that adiponectin may regulate nociception by inhibition of neuroinflammation in the somatosensory nervous system.
Methods

Animals and experimental design
Adult male adiponectin knockout (KO) mice (6e8 weeks) with a C57BL/6J background, and age-matched wild type (WT) mice weighting 25e30 g were given food and water ad libitum and housed five to six per cage, at 22 C, 50% humidity, on a 12 h light:12 h dark schedule. 11 The procedure was approved by the Committee on the Use of Live Animals in Teaching and Research, the University of Hong Kong and relevant aspects of the Animal Research-Reporting In Vivo Experiments guidelines were followed. The study included a total number of 50 mice (25 WT and 25 KO mice), which were allocated randomly using online software (http://www.randomization.com/) to naïve group (n¼5 from each breed), sham group (including two cohorts: Day 7 for western blotting test and Day 21 for behavioural test, n¼5 from each breed), and partial sciatic nerve ligation (pSNL) group (including two cohorts: Day 7 and Day 21, n¼5 from each breed). The behavioural tester was blinded as to the treatment group. The sample size was determined based on the minimum average relatedness by the method described by Charan and Kantharia. 23 The naïve group of WT and KO mice without any treatment were perfused for immunofluorescence staining. All the animals used for behavioural test and western blotting assessment were culled by overdose of sodium pentobarbital (Virbac, Milperra, Australia) followed by tissue collection.
Neuropathic pain model
The pSNL model is a well-characterised neuropathic pain model and was induced as previously described. 24 Briefly, anaesthesia was induced with isoflurane 4% in oxygen and maintained with isoflurane 2e2.5% in oxygen. The depth of anaesthesia was indicated by the lack of pedal withdrawal response to a nociceptive stimulus, monitoring of heart rate (300e500 beats min
À1
), respiration rate (100e200 bpm), saturated pulse oxygenation (i.e. mucous membrane colour, pink or pale pink), and body temperature (36.5e38 C), which were monitored every 15 min during surgery. After hair removal and sterilisation of the area with ethanol 75% and betadine, a small incision was made below the right biceps femoris. Blunt dissection was performed to separate the gluteus superficialis and expose the sciatic nerve. Upon isolation of the nerve from the fascia, a tight ligation approximately one-third to one-half the diameter of the sciatic nerve was made to the nerve with 7-0 silicon-treated silk suture. The wound was then closed with non-absorbable monofilament 5-0 Nylon sutures. Mice were carefully monitored during surgery until recovery from anaesthesia. Sham operation was performed in the same way, except nerve ligation was not carried out. Mice after pSNL consistently developed ipsilateral mechanical allodynia, which peaked by Day 1 postsurgery and remained at a similar level until Day 21, the period in which the study was carried out.
Behavioural tests
Mechanical allodynia
Paw withdrawal threshold (PWT) as an indicator for mechanical allodynia was assessed on both ipsilateral and contralateral hind paws of mice using an ElectrovonFrey Aesthesiometer (IITC, Woodland Hills, CA, USA). Animals were placed on a raised mesh grid and covered with a transparent Plexiglas box to contain the animal in a red-light/dark environment. They were allowed to habituate the new test environment for 30 min before testing. Filaments in order of increasing force were applied to the middle of the plantar surface of each paw (avoiding the footpads) from below, for 4e6 s or until the filament slightly bent. After the first positive withdrawal response to a particular filament, the von Frey test was repeated three times, using this filament, to ensure reproducibility. The threshold readings (g) were recorded and averaged.
Thermal allodynia and hyperalgesia
Paw withdrawal latency (PWL) to innocuous (thermal allodynia) or noxious heat (thermal hyperalgesia) was measured on both ipsilateral and contralateral hind paws of mice using a Hargreaves apparatus (IITC). Mice were placed within a Plexiglas box on a transparent glass platform and allowed to habituate to the environment for 30 min. An infrared beam with adjustable intensity in 1% increments room temperature to 250 C beneath the glass platform was applied at the plantar surface of hind paw. Innocuous (20% intensity, cut-off time 20 s) or noxious (50% intensity, cut-off time 10 s) heat stimulus was applied to determine the PWL. Three individual readings were taken in each animal with at least a 5 min interval and averaged.
Immunofluorescence staining
Animals were terminally anaesthetised using sodium pentobarbital and perfused with 150 ml of polyformaldehyde 4%, after 200 ml of ice-cold saline. Dorsal root ganglions (DRGs, L5), lumbar spinal cords (L3-5), and somatosensory cortex were harvested, post-fixed and dehydrated in a gradient sucrose solution overnight. Specimens were then frozen in optimal cutting temperature (OCT) cryo-gel and cryosections (15 mm thickness) were cut using a microtome cryostat (Leica Microsystem, Wetzlar, Germany). Sections were stored at À80 C or directly washed with phosphate buffered saline three times, for 5 min each time. After blocking of non-specific binding, sections were incubated with primary antibodies (details provided in the Supplementary material available online) at 4 C overnight, followed by donkey anti-rabbit, mouse, or guinea pig secondary antibodies conjugated with Alexa Fluor 488, 568, or 647 (1:1000; Thermo Fisher Scientific, Waltham, MA, USA). Appropriate negative controls (without primary antibody) for specificity were carried out. Images of WT and KO mice were acquired using confocal microscopy (LSM 780, Carl Zeiss, Oberkochen, Germany) and the intensity of these images was measured using Image-J (National Institutes of Health, Bethesda, MD, USA) as previously described. 25 
Western blotting
Dorsal spinal cords from lumbar segments (L3-5) and somatosensory cortex were harvested from mice 7 days after sham operation or pSNL and lysed in Laemmli buffer (50 mM TriseHCl, pH7.5, sodium dodecyl sulfate 0.5%, 2-mercaptoethanol 5%) with protease inhibitor cocktail 1% (MilliporeSigma, St. Louis, MO, USA). Proteins were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis on 8% Tris-acetate gels before transfer to polyvinylidene difluoride membrane. After blocking with bovine serum albumin 5%, membranes were incubated overnight at 4 C with mouse antibodies against proteins of interest or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as loading control, as detailed in the online Supplementary information, followed by incubation with peroxidase-conjugated secondary antibodies; goat anti-mouse or goat anti-rabbit IgG (1:10 000; Cell Signaling Technology, Danvers, MA, USA) for 1 h at room temperature. Blots were detected by chemiluminescence using X-ray film. Films were scanned for grey-scale densitometric analysis using Image-J (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
All numerical data were presented as individual raw data points with the standard deviation. The D'AgostinoÀPearson omnibus normality test was performed before further analysis. Data from behavioural tests were compared using twoway analysis of variance (ANOVA) followed by Tukey's post hoc test. Immunofluorescence staining was analysed by unpaired two-tailed Student's t-test and data from western blot were analysed by two-way ANOVA followed by Sidak's post hoc test. The non-parametric KruskalÀWallis test was used when the data were not normally distributed. A P value <0.05 was considered as significant. All analyses were carried out using GraphPad Prism 6 software (GraphPad Software Inc, La Jolla, CA, USA).
Results
Behavioural changes in adiponectin KO mice
Basal PWLs to innocuous thermal stimulus before surgery were significantly lower for both left (35% reduction) and right (40% reduction) paws of KO mice than those of WT mice (P<0.01, n¼5, Fig. 1a ). PWL for right paws (i.e. ipsilateral side) of WT and KO mice was significantly decreased by pSNL but not sham operation. An increase of PWL from left paws (i.e. contralateral) of WT mice after pSNL was seen from Day 3 to Day 14, compared with Sham-WT mice, while there was no difference in contralateral PWL between pSNL-KO and Sham-KO mice. It is important to note that PWLs in KO mice were significantly lower than those in the WT group after pSNL across 21 days from Day 3 at both ipsilateral (43% reduction) and contralateral (65% reduction) sides (P<0.01, n¼5, Fig. 1a) . Similarly, PWL in response to noxious heat was significantly lower in KO mice compared with the WT mice before surgery (51% reduction on the left and 43% reduction on the right, P<0.01, n¼5) and 3 days after surgery (41% reduction on the ipsilateral side and 46% reduction on the contralateral side, P<0.01, n¼5, Fig. 1b) . In contrast, PWT was not different between WT and KO mice either before or after pSNL, but decreased after pSNL from Day 3 to Day 21 (Fig. 1c) .
Expression of AdipoRs and neuroinflammationassociated mediators in DRG
Dual-labelled immunofluorescence of DRGs for AdipoR1 and AdipoR2, plus neuronal marker NeuN or satellite glial cell marker glutamine synthetase (GS) showed that AdipoR1 was located in the GS-immunoreactive (IR) satellite glial cells which surround the NeuN-IR neurones, while AdipoR2 was present in NeuN-IR primary sensory neurones but not in satellite glial cells (Fig. 2a and b) . Although expression of AdipoR1 and AdipoR2 was not different between WT and KO mice (data not shown), the relative fluorescence intensity of neuroinflammation-associated mediator p-p38 MAPK and TRPV1 was significantly higher in DRG neurones of KO mice than that in WT mice (p-p38, 3.1-fold, P<0.05, n¼5; TRPV1, 2.3-fold, P<0.01, n¼5, Fig. 2c and d) . We further explored the expression and distribution of CGRP in DRGs and spinal dorsal horns where the central terminals of peripheral sensory neurones are located. CGRP expression was significantly elevated in DRGs of KO mice, compared with WT mice (two-fold, P<0.05, n¼5, Fig. 2e and f) . Although the expression of CGRP in the spinal dorsal horns was not different between WT and KO sham groups, it increased after pSNL (WT: 1.4-fold; KO: 1.3-fold, P<0.05, n¼5, Fig. 2e and f) . It is worth noting that the distribution of CGRP in the central terminal of DRG neurones was shifted from superficial layers (laminae IeII) to deep layers (laminae IIIeV) in KO mice (Fig. 2e) .
Expression of AdipoRs and neuroinflammatory mediators in the spinal cord
Immunofluorescence staining showed that both AdipoR1 and AdipoR2 were present in the dorsal horn (Fig. 3a) . AdipoR1 was co-localised with the astrocyte marker glial fibrillary acidic protein and microglial marker Iba-1, while AdipoR2 was mainly co-localised with NeuN and less so with Iba-1 (Fig. 3b) . The difference in expression of AdipoR1 and AdipoR2 between KO and WT mice with pSNL or sham was assessed by western blotting. Expression of AdipoR1 but not AdipoR2 was significantly higher after pSNL in WT (2.2-fold) and KO (two-fold) mice (P<0.01, n¼5), but there was no difference in AdipoR1 or AdipoR2 between WT and KO mice with or without pSNL (Fig. 3c) .
In the sham group, the number of p-p38-and TRPV1-positive stained cells in KO mice was significantly higher than that of WT mice (Fig. 4a) . In addition, in KO mice, p-p38 positive cells were co-localised with microglia marker Iba-1. Protein expression of p-p38 MAPK and TRPV1 in the spinal dorsal horn was significantly higher in KO compared with WT mice (p-p38, 2.8-fold, P<0.01, n¼5; TRPV1, 1.9-fold, P<0.01, n¼5, Fig. 4b and c) . This increase was further exaggerated after pSNL at Day 7 after injury (p-p38, 1.2-fold, P<0.01, n¼5; TRPV1, 1.3-fold, P<0.01, n¼5, Fig. 4b and c) . Consistently, the expressions of activation marker of microglia Iba-1 and proinflammatory cytokines TNF-a, IL-1b, and IL-6 were significantly higher in spinal cords of KO mice, compared with WT mice (Iba-1, Sham-KO vs Sham-WT: 2.5-fold; pSNL-KO vs pSNL-WT: 1.5-fold, P<0.05, n¼5; TNF-a, Sham-KO vs Sham-WT: 1.6-fold; pSNL-KO vs pSNL-WT: 1.7-fold, P<0.05, n¼5; IL-1b, Sham-KO vs Sham-WT: 1.5-fold; pSNL-KO vs pSNL-WT: 1.5-fold, P<0.05, n¼5; IL-6, Sham-KO vs Sham-WT: 2.3-fold, P<0.05, n¼5; pSNL-KO vs pSNL-WT: 1.3-fold, P<0.05, n¼5; Fig. 4deg ). In addition, the central sensitisation marker GluN2B became phosphorylated/activated after pSNL in both types of mice (pSNL-WT vs Sham-WT: 4.6-fold elevation, P<0.01, n¼5; pSNL-KO vs Sham-KO: 3.8-fold elevation, P<0.01, n¼5, Fig. 4h ). Another neuronal activation and central sensitisation marker, extracellular regulated protein kinase (ERK) was also activated in KO mice before and after pSNL (Sham-KO vs Sham-WT: 1.9-fold elevation, P<0.01, n¼5; pSNL-KO vs pSNL-WT: 1.4-fold elevation, P<0.01, n¼5, Fig. 4i ).
Expression of AdipoRs and neuroinflammatory mediators in the somatosensory cortex
AdipoR1 expression was widely distributed across the cerebrum including somatosensory cortex (Fig. 5a) , while AdipoR2 was expressed in a relatively lower concentration (data not shown). In the somatosensory cortex, AdipoR1 was colocalised with microglial marker Iba-1 in WT mice and also neuronal marker NeuN in KO mice, while AdipoR2 was mainly co-localised with NeuN and less with Iba-1 (Fig. 5b) . Protein expression of AdipoR1 was significantly increased in KO mice compared with WT mice (1.8-fold before pSNL and 1.5-fold after pSNL, P<0.05, n¼5), however, no significant difference in protein expression of AdipoR2 was observed between WT and KO mice with or without pSNL (Fig. 5c) .
In the somatosensory cortex, TRPV1 co-localised with AdipoR1 and was also present in p-p38-IR/Iba-1-positive cells in WT and KO mice (Fig. 5d) . However, it was only present in the excitatory cortex with vGluT2-IR/NeuN-positive cells in KO mice, but not in WT mice (Fig. 5d) . Protein expression of p-p38 MAPK and TRPV1 in the somatosensory cortex was significantly increased in KO mice, compared with WT mice (p-p38, 1.7-fold before pSNL and 1.3-fold after pSNL, P<0.05, n¼5; TRPV1, 1.9-fold before pSNL and 1.3-fold after pSNL, P<0.05, n¼5, Fig. 5e ).
Discussion
Our current study provides evidence that genetic depletion of adiponectin was associated with hypersensitivity to both innocuous and noxious thermal stimuli and worsened with thermal challenge after peripheral nerve ligation. A corresponding elevation in p-p38 MAPK and TRPV1 in the peripheral and central nervous system was found in adiponectin KO mice, along with increased expression of proinflammatory cytokines in the spinal dorsal horn. This suggests a critical role for adiponectin in regulation of thermal sensitivity in physiological and pathological conditions. The findings indicate that adiponectin is not only essential for maintenance of normal thermal sensitivity, but also capable of inducing analgesia via inhibition of neuroinflammation after peripheral nerve injury in mice.
Adiponectin is a circulating endocrine hormone mainly secreted by adipocytes. A number of studies about adiponectin focus on its function in the liver and muscle tissues, showing that it participates in glucose and lipid metabolism. 26, 27 Adiponectin is also beneficial in protection against heart diseases, such as myocardial ischemia-reperfusion injury 28 and can promote circulating endothelial cell repair by suppressing p38 MAPK pathways in diabetic mice. 29 As adiponectin was detected in cerebrospinal fluid, 7 it may influence various neurological processes including neurodegeneration, analgesia, and anti-inflammation. Indeed, accumulating evidence shows that adiponectin participated in protective mechanisms with compensating increase of adiponectin and AdipoRs in cortex and hippocampus in peripheral and central neuropathy in animal models, while concentrations in plasma decreased. 30, 31 In the present study, we targeted the roles of adiponectin in the somatosensory nervous system. We found that adiponectin KO mice were more susceptible to innocuous and noxious thermal stimuli than WT mice, and this susceptibility was exacerbated by peripheral nerve injury. Moreover, we revealed that adiponectin might exert an analgesic effect in different pathways via its receptors AdipoR1 and AdipoR2, as they locate in different types of cells in the peripheral and central nervous systems (Fig. 6 ).
In the peripheral nervous system, we identified that AdipoR1 was mainly expressed by satellite glial cells, while AdipoR2 was abundant in DRG neurones. Despite the lack of difference in expression of AdipoRs between KO and WT mice, over-expression of p-p38 MAPK, TRPV1, and CGRP was found in DRG neurones of KO mice. Previous studies have illustrated that p38 MAPK plays a pivotal role in mechanical allodynia and thermal hyperalgesia after nerve injury, 32, 33 and expression of p-p38 MAPK was elevated in DRG neurones after chronic constriction injury of the sciatic nerve. 34 Moreover, TRPV1 is a heat-sensitive receptor in DRG neurones and its expression is upregulated after sensory nerve damage, 35 related to activation of p38 MAPK in primary sensory neurones. 36 Furthermore, activation of TRPV1 can induce CGRP release which contributes to inflammation-induced pain. 18 Based on these previous findings, our study suggests that adiponectin may regulate thermal nociceptive sensitivity by suppressing the activation of p38 MAPK, TRPV1, and CGRP in DRG neurones, presumably through binding to AdipoR2. Furthermore, there were also changes in the initial relays within the spinal dorsal horn that contribute to the hyperexcitability induced by pSNL. We found that TRPV1 in the spinal dorsal horn was not only increased in the superficial layers (i.e. laminae IeII) where relay of noxious signals is transduced by high threshold fibres, but also expressed in the deep layers (i.e. laminae IIIeV) where transduction is via low threshold fibres. TRPV1 in the central terminal of DRG neurones in the spinal dorsal horn is involved in exaggerating pain in inflammation 37 and its activation contributes to nerve injury-induced hyperalgesia in injured and uninjured nerves. 38 Spinal CGRP is initially derived from high-threshold DRG neurones and is usually present in the superficial layers of the dorsal horn. 37 Increased CGRP expression in low-and high-threshold DRG neurones and in the laminae IIIeIV of the spinal dorsal horn has been found after peripheral nerve injury. 38 This is similar to our findings that CGRP expression was increased in deep (lamina III-V) layers of the spinal dorsal horn in adiponectin KO mice after pSNL. Our findings indicate that adiponectin may modulate thermal allodynia and hyperalgesia by inhibiting the expression of TRPV1 and CGRP at the central terminals in normal or mice after partial nerve constriction. In the central nervous system, we demonstrated that AdipoR1 was highly expressed in spinal microglia, whereas AdipoR2 was enriched in spinal dorsal horn neurones. Activation of spinal microglia along with increased p-p38 MAPK, TNF-a, IL-1b, and IL-6 was found in the spinal dorsal horn of the KO mice. In neuropathic or inflammatory pain states, spinal microglia become activated for an extended period of 7 days and produced numerous noxious mediators via the p38 MAPK pathway, which leads to excitation of spinal neurones. 33, 34, 39 Our study showed that the expression of p-p38 in activated microglia with increased marker protein Iba-1 was enhanced in the spinal cord, and this may underlie the mechanisms of hypersensitivity caused by depletion of adiponectin and nerve injury. It is known that released pro-inflammatory cytokines, such as TNF-a, IL-1b, and IL-6, from the activated spinal microglia are upregulated and contribute to mechanical allodynia and thermal hyperalgesia after nerve injury. 40 Intrathecal injection of a TNF-a antagonist can block the activation of p38 MAPK in the spinal cord after nerve injury. 41 An ex vivo study showed that the release of IL-1b from a lipopolysaccharide-treated spinal dorsal horn slice was prevented by inhibition of glial metabolism and inhibitors of p38 MAPK. 20 Therefore, increase of pro-inflammatory cytokines in adiponectin KO mice is presumably a p38 MAPK-dependent process. Intrathecal injection of IL-1b upregulated expression of phosphorylated p38 MAPK in the spinal cord, whilst pretreatment with a p38 MAPK inhibitor or microglia activation inhibitor can attenuate intrathecal IL-1b-induced thermal hyperalgesia. 42, 43 This suggests that neuroinflammation can be exacerbated by activation of microglia. Consistent with previous findings that proinflammatory cytokines promote neuronal activity, 19 we identified, here, that activated microglia and elevated expression of TNF-a, IL-1b, and IL-6 in the spinal cord might contribute to thermal hypersensitivity induced by depletion of adiponectin and nerve injury. Indeed, we found that the central sensitisation marker, p-GluN2B, 44 and neuronal activation marker, p-ERK 45 were increased after nerve injury in both WT and KO mice. Importantly, there was a significant difference in spinal p-ERK expression between WT and KO mice. The results imply that adiponectin deficiency caused spinal neurone hyperexcitation, which can be transmitted to higher regions of the brain, thereby leading to accentuated perception of pain. Therefore, we investigated the alteration of adiponectin and its receptors in relation to potential signalling molecules in the somatosensory cortex where pain is perceived. We found that AdipoR1 was mainly located in microglia in WT mice and was also present in neurones in KO mice, and its protein concentration was increased in KO mice before and after pSNL, while AdpioR2 was largely expressed in neurones without responsiveness to adiponectin ablation and nerve injury. The results imply that AdipoR1 in cortical neurones is involved in thermal hyperalgesia. Similar to AdipoR1, TRPV1 was recently found in microglia of the brain modulating microglial-neuronal communication by promoting the release of extracellular vesicles from microglia, and in neurones after nerve injury strengthening the excitatory synaptic transmission. 22 In the present study, we found TRPV1 was co-localised with AdipoR1 and also existed in p38 MAPK-IR microglia and vGluT2-IR excitatory neurones in KO mice. Our findings indicate that adiponectin may limit the activation of TRPV1 in microglia and cortical neurones to reduce the responsiveness to thermal stimuli. Of note, although the changes of AdipoR1 and AdipoR2 in WT and adiponectin KO mice in the setting of neuropathic pain have been examined in the current study, interventions such as gain-of-function and loss-of-function studies would be needed to examine the exact role of AdipoR1 and AdipoR2 in neuropathic pain. Moreover, in the current study, Day 21 post-operation was used as the end point and studies beyond 21 days after surgery would provide greater insight on the role of adiponectin in ongoing neuropathic pain. In addition, the roles of adiponectin and its receptors were examined in the cortex, but other brain areas in pain pathways, such as periaqueductal gray and thalamus may also be important.
In conclusion, adiponectin may be involved in the control of thermal nociceptive sensitivity via p38 MAPK/TRPV1 in the peripheral and central nervous systems in physiological and pathological conditions. Our study suggests a role for adiponectin in neuropathic pain may present a treatment strategy in patients with adiponectin disorders, such as obesity and diabetes.
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